7^th World Conference on Pharmaceutical Science and Drug Manufacturing

As part of the "7^th World Conference on Pharmaceutical Science and Drug Manufacturing" that is scheduled to take place on the 18^th and 19^th of March in Flora Creek Deluxe Hotel Apartments, Dubai, United Arab Emirates, many thought-provoking speakers will address key points in the critical debate on financing policies that help local manufacturing of pharmaceuticals across the world and how industry leaders seek to facilitate accelerated industrial development globally.

Participants taking part in the various sessions will be afforded the opportunity to listen, learn and discuss with technical experts from around the world and from different backgrounds as they share their views and insights on how to catalyze local production of essential medicines in countries around the world.

Attendees will interact with decision-makers, sponsors and partners and discuss how to maximize opportunities for pharmaceutical companies to expand their presence and partner with other manufacturing companies from across the globe, with the aim to access the market and increase their market share.

The overall objective of the conference is to promote solid activities that will develop unrestricted access to affordable and quality drugs and catalyze production globally, all across the world.

To be concise, the 7^th World Conference On Pharmaceutical Science and Drug Manufacturing aims to

1. Unify leadership within the Pharma industry at large by working with pharmaceutical companies, business leaders and other stakeholders to establish a viable global pharmaceutical science and manufacturing industry.

2. Genuinely understand both the short-term and long-term cost reduction opportunities through acquisition methods to guarantee sustainable and affordable stocks of basic drugs.

3. Effectively identify opportunities to expand pharmaceutical manufacturing all over the globe through -

• Enhanced acquisitions,
• Innovative service distribution,
• Expansion of research and development, and
• Streamlined, well-organized and cooperative regulatory capacities Secure economic incentives and tax options
• Enhanced platforms for global collaboration as well as the facilitation of business-to-business partnerships.